Skip to main navigation
  • About
    • Overview
    • Leadership
  • Area of Focus
    • Congestion in Heart Failure
    • Outpatient Parenteral Antimicrobial Treatment (OPAT)
  • Products, Research and Development
    • FUROSCIX® (furosemide injection) 80mg/10mL for subcutaneous use
    • scCeftriaxone
    • Clinical Development & Medical Affairs
  • Investor Relations

    Investor Relations

    • Investor Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
    • Financial Information
      • SEC Filings
    • News & Events
      • News Releases
      • Event Calendar
      • Presentations
    • Investor Resources
      • Investor Faq
      • Information Request
      • E-mail Alerts
      • IR Contacts
    • ESG
  • Media Resources
  • Careers
  • Contact Us
  • Legal
    • Privacy Policy
    • Terms of Use
scPharmaceuticals

sec filing details

SEC Filing Details

Form
4
Filing Date
12/19/22
Document Date
12/15/22
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
scPharmaceuticals, Inc.
Issuer
scPharmaceuticals Inc.
Filer
Nokes Rachael

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR Contacts
  • About
    • Overview
    • Leadership
  • Area of Focus
    • Congestion in Heart Failure
    • Outpatient Parenteral Antimicrobial Treatment (OPAT)
  • Research and Development
    • FUROSCIX® (furosemide injection) for subcutaneous administration
    • scCeftriaxone
    • Clinical Development & Medical Affairs
  • Investor Relations

    Investor Relations

    • Investor Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
    • Financial Information
      • SEC Filings
    • News & Events
      • News Releases
      • Event Calendar
      • Presentations
    • Investor Resources
      • Investor Faq
      • Information Request
      • E-mail Alerts
      • IR Contacts
    • ESG
  • Careers
    • Working at scPharmaceuticals
    • Career Opportunities
  • Contact
  • Legal
    • Privacy Policy
    • Terms of Use
scPharmaceuticals

scPharmaceuticals is a pharmaceutical company focused on developing and commercializing innovative solutions to enhance the potential of outpatient care.

© 2023 scPharmaceuticals, Inc. All rights reserved. Privacy Policy Terms of Use

Contact

2400 District Avenue, Suite 310
Burlington, MA 01803
617-517-0730
info@scpharma.com

Menu

  • About
  • Areas of Focus
  • Products, Research and Development
  • Investor Relations
  • Media Resources
  • Careers
  • Contact Us